Cart
sales@molnova.com
PI3Kδ-IN-3
CAS No. 1431540-99-6
PI3Kδ-IN-3( —— )
Catalog No. M34137 CAS No. 1431540-99-6
PI3Kδ-IN-3 (TC KHNS 11) is a PI3Kδ inhibitor with an IC50 value of 9 nM.PI3Kδ-IN-3 has a favorable pharmacokinetic profile and inhibits B cell function.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 185 | In Stock |
|
| 10MG | 295 | In Stock |
|
| 25MG | 503 | In Stock |
|
| 50MG | 711 | In Stock |
|
| 100MG | 995 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2000 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePI3Kδ-IN-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionPI3Kδ-IN-3 (TC KHNS 11) is a PI3Kδ inhibitor with an IC50 value of 9 nM.PI3Kδ-IN-3 has a favorable pharmacokinetic profile and inhibits B cell function.
-
DescriptionPI3Kδ-IN-3 (Compound 11) is a PI3Kδ inhibitor (IC50: 9 nM). PI3Kδ-IN-3 inhibits B cell function. PI3Kδ-IN-3 has good pharmacokinetic properties.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3K
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1431540-99-6
-
Formula Weight492.53
-
Molecular FormulaC28H24N6O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=O)(C=1C=C(C=2C3=C(C=CC(=C3)C=4C=C(C#N)C(OC)=NC4)N=CN2)C=CC1)N5CCN(C(C)=O)CC5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hoegenauer K, et al. Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors. ACS Med Chem Lett. 2016 Jun 2;7(8):762-7.?
molnova catalog
related products
-
LY294002
A classic, broad-spectrum PI3K inhibitor with IC50 of 0.5/0.57/0.97 uM for PI3Kα/δ/β, respectively.
-
iMDK
iMDK quarterhydrate is a potent PI3K inhibitor that inhibits the growth factor MDK (also known as midkine or MK). iMDK quarterhydrate synergistically inhibits non-small cell lung cancer (NSCLC) with MEK inhibitors without harming normal cells and mice.
-
Tenalisib (RP6530)
Tenalisib shows selectivity over PI3K α (>300-fold) and β (>100-fold) isoforms. Tenalisib exhibits modest proliferation inhibition in both HEL-RS and HEL-RR cells.
